Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of centrally acting agents and neuromodulatory drugs. Its structure supports the formation of bioactive molecules that interact with neurotransmitter systems. The presence of both hydroxyl and methylamino groups in a constrained cyclobutane ring enhances its utility in medicinal chemistry for optimizing metabolic stability and target binding. Commonly employed in the preparation of compounds targeting neurological disorders, including depression, anxiety, and cognitive dysfunction. Also utilized in research settings to explore structure-activity relationships in small molecule drug candidates.